EC Gives European Consortium $16M to Study How RNAi Can Help Rx Development

Apr 19, 2007

NEW YORK (GenomeWeb News) — A UK research institute will lead an €11.8-million ($16-million) research consortium that will study the potential uses for RNA interference in treating disease.

The Sainsbury Institute at the John Innes Center in Norwich said the European Commission-funded consortium will comprise 17 labs in nine European countries. The group will be called Silencing RNAs: Organizers and Coordinators of Complexity in Eukaryotic Organisms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Out of the Books

NPR reports that Turkish high school students will no longer study evolution.

Mountainside Sequencing

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

Better Treatments Sought

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

This Week in PNAS

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.

Featured White Papers

High Throughput RT-qPCR for Gene Expression Analysis

Sep

12

Featured Webinar

GenomeWeb/ABRF 2017 Webinar Series: Next-Generation CRISPR: New Tools for Efficient Genome Engineering

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines.

Main menu